BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.

Beijing Centergate Technologies (holding) Co., Ltd.

000931

CNE000001030

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-06-30 EDT			5-day change	1st Jan Change
3.56 ^CNY	+0.85%		+2.30%	-39.35%

04-26	Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Beijing Centergate Technologies Co., Ltd.(SZSE:000931) dropped from Shenzhen Stock Exchange Component A Share Index

January 02, 2017 at 12:00 am

Beijing Centergate Technologies (holding) Co., Ltd. has been removed from Shenzhen Stock Exchange Component A Share Index.

Latest news about Beijing Centergate Technologies (holding) Co., Ltd.

Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-18	CI
Centergate Technologies to Build 80 Million Yuan Production Base	03-01	MT
Centergate Technologies Registers Diarrhea Treatment	12-21	MT
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-14	CI
Beijing Centergate Technologies Co., Ltd. Announces Board Changes	22-02-23	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
Beijing Centergate Technologies Co., Ltd.(XSEC:000931) dropped from S&P Global BMI Index	21-06-21	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-26	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-14	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-26	CI
Beijing Centergate Technologies Co., Ltd.(XSEC:000931) added to S&P Global BMI Index	20-09-21	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-17	CI
Gome Holding Group Recommends Beijing Centergate Technologies to Provide Guarantee for Beijing Huasu Pharmaceutical Credit Application	20-04-17	CI
Gome Holding Group Recommends Beijing Centergate Technologies to Provide Liquidity Credit Guarantee for Shandong Hwellso Pharmaceutical	20-04-17	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-14	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-28	CI

Chart Beijing Centergate Technologies (holding) Co., Ltd.

Duration

Period

Chart Beijing Centergate Technologies (holding) Co., Ltd.

More charts

Beijing Centergate Technologies Holding Co Ltd is a China-based company principally engaged in biomedicine, personal care products, elderly care services and other businesses. The Company operates its businesses through four segments. The Biopharmaceutical segment is mainly engaged in the production and sales of external reagents, tablets, injections and other products. The Commercial Concrete segment is mainly engaged in the production and sales of concrete. The Elderly Care and Health segment mainly provides elderly care services. The Other segments mainly provide property management services, sales of existing properties, hotel business and others. The Company mainly operates its businesses in the domestic market, with North China and Northeast China as its main markets.

Sector

Pharmaceuticals

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.	-39.35%	366M
ELI LILLY AND COMPANY	+56.86%	815B
NOVO NORDISK A/S	+43.90%	641B
JOHNSON & JOHNSON	-6.57%	352B
MERCK & CO., INC.	+17.32%	314B
ABBVIE INC.	+9.94%	303B
ASTRAZENECA PLC	+16.08%	242B
ROCHE HOLDING AG	+2.29%	224B
NOVARTIS AG	+13.96%	218B
AMGEN INC.	+7.98%	168B